ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PBTH Prolor Biotech, Inc.

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Prolor Biotech, Inc. AMEX:PBTH AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

26/09/2013 10:07pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 

  001-34676

 

PROLOR BIOTECH, INC.

(Exact name of registrant as specified in its charter)

 

7 Golda Meir Street

Weizmann Science Park

Nes-Ziona, Israel 74140

(866) 644-7811

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common stock, $0.00001 par value per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   x
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date: one (1)

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

   
Date: September 26, 2013     By:   /s/ Steven D. Rubin
    Name:   Steven D. Rubin
    Title:   Vice President

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

 

 

 

 

1 Year Prolor Biotech, Inc. Chart

1 Year Prolor Biotech, Inc. Chart

1 Month Prolor Biotech, Inc. Chart

1 Month Prolor Biotech, Inc. Chart

Your Recent History

Delayed Upgrade Clock